MPM BioImpact LLC - KALVISTA PHARMACEUTICALS INC ownership

KALVISTA PHARMACEUTICALS INC's ticker is KALV and the CUSIP is 483497103. A total of 103 filers reported holding KALVISTA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.38 and the average weighting 0.3%.

Quarter-by-quarter ownership
MPM BioImpact LLC ownership history of KALVISTA PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$5,565,736
-18.8%
577,958
-24.1%
1.49%
+7.7%
Q2 2023$6,853,842761,5381.38%
Other shareholders
KALVISTA PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Stonepine Capital Management, LLC 422,310$10,849,0005.86%
COMMODORE CAPITAL LP 214,467$5,510,0002.20%
Vivo Capital, LLC 1,863,296$47,868,0001.68%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 214,533$5,486,0001.45%
Nicholas Investment Partners, LP 594,130$15,263,0001.06%
Altium Capital Management LP 128,130$3,292,0000.91%
Affinity Asset Advisors, LLC 100,000$2,569,0000.87%
SILVERARC CAPITAL MANAGEMENT, LLC 50,000$1,285,0000.70%
APIS CAPITAL ADVISORS, LLC 30,000$771,0000.70%
Birchview Capital, LP 40,000$1,028,0000.61%
View complete list of KALVISTA PHARMACEUTICALS INC shareholders